| Position | Action |
|---|---|
| Current exposure within beta-adjusted risk budget | Maintain current position size |
| 20% drawdown from $483 (~$386) would impair portfolio | Trim toward target weight only on relief bounce toward $514 |
| On weakness toward $430 capitulation low | Do not trim—residual weight with defined collar preserves structural exposure |
AMD's -17% correction is healthy profit-taking rebalancing within a dominant long-term uptrend, creating an asymmetric buying opportunity at $483 with 31.3x forward P/E for a company growing 38%+ with record Data Center revenue and accelerating FCF.
| Indicator | Value | Signal |
|---|---|---|
| close_10_ema | $490.47 | bearish |
| close_50_sma | $514.08 | bearish |
| close_200_sma | $318.29 | bullish |
| rsi | 46.89 | neutral |
| macd | -8.34 | bearish |
| macd_signal | -6.08 | bearish |
| macd_histogram | -2.26 | bearish |
| boll_mid | $503.45 | bearish |
| boll_upper | $568.39 | bearish |
| boll_lower | $438.50 | neutral |
| atr | $38.26 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Conditional HOLD with collar overlay; hard stop at $407
HOLD posture with explicit collar hedge structure. The consensus HOLD is correct and reflects the value-vs-momentum tension—secular thesis intact (data center doubled, 41% forward guide, $8.84B FCF, $8.5B net cash, +52% above 200 SMA) but technical evidence is genuine deterioration (lower highs sequence, MACD histogram at -2.26 and widening, 50 SMA at $514 as hard dynamic resistance). Do not add on this weakness; do not trim aggressively into defended $430 support. The right posture is conditional maintenance with explicit hedge structure, not "stay fully loaded" or "actively trim" in isolation.
When: Decisive close above $514 on volume
Then: Re-engage with defined-risk overlay
· concedes: Use $420 level (July 29 panic low) as a hard stop; Position size to beta of 2.49; Hold for Q3 print in late October — timeframe is 6–12 months; Technical indicators (MACD, RSI, price below multiple MAs) do show short-term weakness
AMD's risk/reward at $483 is unfavorable due to accelerating downside momentum, distribution confirmed by volume, and a forward P/E of 31x priced for near-perfect execution that leaves no margin of safety in a high-beta (2.49) stock with structural competitive and execution risks.
· concedes: Q2 earnings results were record-level; Long-term AI infrastructure trend is structurally intact; AMD has genuine data center momentum and MI300X deployments; The -17.3% correction removes some speculative froth from valuation; Waiting for confirmation is prudent risk management
→ vs conservative: The conservative analyst's $407 stop is too tight against a $38 ATR, treating a healthy profit-taking rebalance as regime change driven by recency bias anchoring on the last red candle
→ vs conservative: The conservative analyst ignores extraordinary fundamentals (doubling data center revenue, 41% forward guide, $8.84B FCF, $8.5B net cash) and is making a category error by conflating a 17% correction with a broken chart
→ vs neutral: The neutral analyst's 'wait and see' stance forfeits the 10-20% recovery during the basing pattern resolution, volunteering to buy the next leg up at $540-$560 instead of holding at $483
→ vs neutral: The neutral analyst is paying a premium for the illusion of certainty in a stock with 2.49 beta where waiting means structurally underperforming the very trend being analyzed
| vwma | $496.55 | bearish |
| price_close | $483.36 | neutral |
| day_high | $498.82 | neutral |
| day_low | $476.06 | neutral |
Support: 476 · 460 · 438.5 · 420 · 318.29 | Resistance: 490.47 · 498.82 · 503.45 · 514.08 · 518 · 568.39
FINAL TRANSACTION PROPOSAL: HOLD. Initiating new positions is premature given deteriorating short-term momentum (MACD histogram widening negative, VWMA declining from $533 to $496, price below all fast MAs). The downtrend lacks reversal confirmation (RSI at 46.89 not oversold, no bullish MACD crossover). Selling is unwarranted given the powerful long-term uptrend (price +52% above 200 SMA) — the drawdown is a correction, not a regime change. Optimal strategy is patience: wait for either a high-conviction support test ($438–$460) with bullish reversal signals (RSI < 35, MACD histogram positive, price reclaims 10 EMA), or a decisive reclaim of the 50 SMA at $514 with volume. Current holders should maintain positions with trailing stops based on 2× ATR (~$407). Preferred entry scenario offers ~3.6:1 risk/reward.
Market Cap
$789.07 B
Share Price
~$485
52-Week Range
$149.22 – $584.73
50-Day MA
$512.95
200-Day MA
$313.16
Beta
2.49
P/E (TTM)
123.6
Forward P/E
31.3
PEG Ratio
1.13
P/B
11.73
EPS (TTM)
$3.91
Forward EPS
$15.46
Book Value/Share
$41.19
Q1'26 Revenue
$10,253M
Q1'26 Gross Profit
$5,416M
Q1'26 Gross Margin
52.8%
Q1'26 Operating Income
$1,476M
Q1'26 Operating Margin
14.4%
Q1'26 Net Income
$1,383M
Q1'26 Diluted EPS
$0.84
Q1'26 R&D Expense
$2,397M
Q1'26 EBITDA
$2,398M
TTM Operating Margin
17.25%
TTM Profit Margin
15.58%
TTM Free Cash Flow
$8.84B
TTM FCF Margin
~21.4%
Cash & Equivalents
$5,585M
Short-Term Investments
$6,762M
Total Liquid Assets
$12,347M
Total Current Assets
$28,628M
Goodwill
$25,344M
Other Intangibles
$16,154M
Total Assets
$79,642M
Total Debt
$3,871M
Stockholders' Equity
$64,462M
Working Capital
$18,122M
Current Ratio
2.61
Debt-to-Equity (Standard)
0.060
Net Cash Position
$8,476M
Q1'26 Operating Cash Flow
$2,955M
Q1'26 CapEx
-$389M
Q1'26 Free Cash Flow
$2,566M
Q1'26 Stock Buybacks
-$355M
Gross Margin (TTM)
~55.7%
ROE (TTM)
10.20%
ROA (TTM)
5.13%
Revenue YoY Growth
+37.9%
OCF YoY Growth
+214%
Strengths
Concerns
AMD is a fundamentally strong, cash-generative semiconductor franchise riding the AI accelerator wave with Q1'26 revenue of $10.3B (+38% YoY) and TTM FCF of $8.84B. The company maintains an exceptionally clean balance sheet with $8.5B net cash, allowing strategic flexibility for M&A or shareholder returns. However, the valuation is demanding (TTM P/E 123.6x) and pricing in aggressive consensus EPS growth to $15.46, while Q1'26 showed the first sequential revenue plateau and margin compression, creating execution risk. The high beta (2.49) suggests significant volatility suitable only for risk-tolerant investors. The report recommends HOLD for current holders and selective accumulation on pullbacks toward the 50-day MA (~$513) for new entrants.